Lv5
1006 积分 2024-05-23 加入
Real world predictors of hypogammaglobulinemia and serious infections in patients receiving ocrelizumab or ofatumumab for the treatment of multiple sclerosis: The REPLACE-MS study
3天前
已完结
儿童神经系统疾病糖皮质激素治疗专家系列建议之三——视神经脊髓炎谱系疾病的治疗
6天前
已完结
萨特利珠单抗治疗复发高风险抗髓鞘少突胶质细胞糖蛋白免疫球蛋白G抗体相关疾病1例
10天前
已完结
Analysis of infection rates in neuromyelitis optica spectrum disorder: Comparing satralizumab treatment in SAkuraMoon, post-marketing, and US-based health claims data
2个月前
已完结
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
2个月前
已完结
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
2个月前
已完结
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial
2个月前
已完结
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial
2个月前
已完结
PNURTURE study: long-term benefits of nusinersen in presymptomatic spinal muscular atrophy (SMA) over 8 years of Follow-up
2个月前
已完结
Risdiplam: A Review in Spinal Muscular Atrophy
2个月前
已完结
皖公网安备34019202002308
